Biosimilars Survey for Patients

Biosimilars Survey for Patients The Gastrointestinal Society represents Canadian patients on a variety of healthcare fronts, including access to medications. We have designed this survey to help us understand your opinions and outlook regarding biosimilar medications. We will use this information anonymously and in aggregate to shape future programming and to inform community members, healthcare [...]

By |2020-09-24T11:11:00-07:00September 25, 2019|News|

Balancing Act: Cost Containment vs. Patient Health Outcomes

Balancing Act: Cost Containment vs. Patient Health Outcomes September 5, 2019 Gail Attara, President & Chief Executive Officer Gastrointestinal Society President, Canadian Society of Intestinal Research Today, the BC Government announced a policy that will require inflammatory bowel disease (Crohn’s disease and ulcerative colitis) patients currently using originator infliximab (Remicade®) to switch to biosimilar infliximab [...]

By |2020-12-04T09:57:31-08:00September 5, 2019|News|

Video: BadGut® Lecture on Medical Cannabis

Video: BadGut® Lecture on Medical Canabis If you have been unable to attend any of our BadGut® Lectures on Medical Cannabis in person, you can view a recording of a lecture we held in Vancouver, BC, on June 10, 2019, by watching the video below. This lecture provides a basic overview of medical cannabis and [...]

By |2022-05-18T12:19:44-07:00July 31, 2019|News|

Survey Results: The Unmet Need of IBD in Canada

Survey Results: The Unmet Need of IBD in Canada The GI Society represents Canadians living with gastrointestinal diseases and disorders, including those who have inflammatory bowel disease (IBD). IBD is an umbrella term that primarily refers to Crohn’s disease and ulcerative colitis. These diseases are characterized by inflammation in the digestive tract. In ulcerative colitis, [...]

By |2020-07-29T14:57:40-07:00January 18, 2019|News|

Pancreatic Exocrine Insufficiency Video

Pancreatic Exocrine Insufficiency Video In individuals with pancreatic exocrine insufficiency, the pancreas doesn’t make enough enzymes to adequately break down food into absorbable components. This can lead to serious nutritional deficiencies, and the symptoms these deficiencies cause. However, with medications and dietary changes, it is possible to manage. Learn more [...]

By |2020-08-10T11:19:17-07:00June 7, 2018|News|
Go to Top